Proteon Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PRTO and buy or sell other stocks, options, and ETFs commission-free!About PRTO
Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease.
CEOTimothy P. Noyes, MBA
CEOTimothy P. Noyes, MBA
Employees27
Employees27
HeadquartersWaltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded2001
Founded2001
Employees27
Employees27
PRTO Key Statistics
Market cap326.06M
Market cap326.06M
Price-Earnings ratio-1.12
Price-Earnings ratio-1.12
Dividend yield—
Dividend yield—
Average volume96.76K
Average volume96.76K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$4.95
52 Week high$4.95
52 Week low$1.04
52 Week low$1.04